VISTAGEN THERAPEUTICS, INC. Debt Instrument, Interest Rate, Stated Percentage
VISTAGEN THERAPEUTICS, INC. (VTGN) had Debt Instrument, Interest Rate, Stated Percentage of 10.00% as of 2014-12-31, per its 10-Q filed 2015-02-17.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2015-02-17
- 2014-12-31: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2014-09-30: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2014-06-30: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
- 2014-03-31: Debt Instrument, Interest Rate, Stated Percentage 10.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2014-12-31 | 10.00% 10-Q · filed 2015-02-17 |
| 2014-09-30 | 10.00% 10-Q · filed 2014-11-19 |
| 2014-06-30 | 10.00% 10-Q · filed 2014-08-12 |
| 2014-03-31 | 10.00% 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |